Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors [Phase 2]
Phase 2 clinical trial update for a thymalfasin-based PRaG mode in advanced refractory solid tumors.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: PRECISE CURATE.AI Pilot Clinical Trial [Phase 1, Phase 2]
Pilot clinical trial update for PRECISE CURATE.AI in solid tumors (Phase 1/Phase 2) with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: First in Human Study of M4344 in Participants With Advanced Solid Tumors [Phase 1]
First-in-human Phase 1 trial of M4344 in participants with advanced solid tumors completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: A Study of TFX05-01 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TFX05-01 in patients with advanced solid tumors, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors [Phase 1, Phase 2]
A Phase I/II study investigating regorafenib in combination with avelumab in various solid tumors, spanning Phase 1 and Phase 2 cohorts.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements [Phase 1, Phase 2]
Clinical trial update evaluating dose optimization of nivolumab and pembrolizumab in solid tumors using the CURATE.AI platform with sequenti…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: A Study of RD14-01 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of RD14-01 in patients with advanced solid tumors is ongoing; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors [Phase 1, Phase 2]
First-in-human study of CDK-002 (exoSTING) in advanced/metastatic, recurrent injectable solid tumors completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) [Phase 1, Phase 2]
Open-label, dose-escalation study of pemigatinib in advanced malignancies (FIGHT-101) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations [Phase 2]
A Phase 2 clinical trial update evaluating ICP-192 in treated patients with advanced solid tumors possessing FGF/FGFR alterations is ongoing…
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]
Phase I/II clinical trial update for VC004 in localized advanced/metastatic solid tumors; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TQB2618 and TQB2450 in advanced solid tumors (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) [Phase 2]
Phase 2 trial evaluating IPI-549 in combination with nivolumab for advanced urothelial carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for T3011 administered intratumorally in advanced solid tumors, including phase 1 and phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Feasibility Study for the Use of Multispectral Optoacoustic Tomography in the Detection of Tumors [NA]
Feasibility study evaluating multispectral optoacoustic tomography for detecting solid tumors; completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
A clinical trial update for T3011 administered intravenously in patients with advanced solid tumors, including various cancer types, spannin…
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating SBRT with pembrolizumab, with or without avelumab/ipilimumab and dendritic cells, in solid tumors includin…
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors. [Phase 2]
Phase 2 trial update evaluating PRaG regimens rechallenge in patients with resistance to PD-1/PD-L1 inhibitors in refractory advanced solid …
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: A Phase II Clinical Trial to Evaluate HLX208 in Advanced Solid Tumor Patients With BRAF V600 Mutation [Phase 2]
Phase II clinical trial update for HLX208 in advanced solid tumors with BRAF V600 mutation is ongoing; no results or status disclosed.
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and activity of pegylated recombinant human arginase (BCT-100) in pediatric cancers; study completed.
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Phase I/IIa study of BR790 in combination with tislelizumab in adults with advanced solid tumors is in early stages with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Clinical Study of ICP-192 in Solid Tumors Patients [Phase 1, Phase 2]
Clinical trial update for ICP-192 in solid tumors across Phase 1 and Phase 2, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Pazopanib and ARQ 197 for Advanced Solid Tumors [Phase 1]
Phase 1 trial update evaluating pazopanib and ARQ 197 in patients with advanced solid tumors; results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: A Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies [Phase 1, Phase 2]
A phase 1/2 trial of tisotumab vedotin in Japanese subjects with advanced solid malignancies has completed.